Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 63187-702

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 63187-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Duloxetine 01)

FDA Label Image

Figure 1 (Duloxetine 02)

FDA Label Image

Figure 2 (Duloxetine 03)

FDA Label Image

Figure 3 (Duloxetine 04)

Figure 3 (Duloxetine 04)
The text is describing a graph showing the percentage of patients improved in terms of pain using a placebo and a medication called CYM80/120mg once daily. The graph also shows the percent improvement in pain from baseline.*
FDA Label Image

Figure 4 (Duloxetine 05)

Figure 4 (Duloxetine 05)
The text shows a graph displaying the percentage of patients who have improved in pain based on baseline data. It shows two treatment options - Placebo and CYM60 mg once daily. The Y-axis displays the percentage of patients while the X-axis shows the percent improvement in pain. The graph shows that patients who took CYM60 mg once daily had a greater improvement in pain compared to those who took the placebo.*
FDA Label Image

Figure 5 (Duloxetine 06)

Figure 5 (Duloxetine 06)
This is a graphical representation of the percentage of patients who experienced improvement in pain from the baseline after taking a placebo versus a CYM60/120 mg dose once daily. The graph shows percentages ranging from 10% to 100% on the y-axis and numerical values ranging from 220 to 280 on the x-axis. The percentage of patients improved after taking CYM60/120 mg appears to be greater than that of the placebo.*
FDA Label Image

63187-702-30 (Duloxetine 08)

63187-702-30 (Duloxetine 08)
This is a prescription medication called Duloxetine 30mg. It comes in a bottle of #30 DR Capsules, and each capsule contains 33.7mg of duloxetine hydrochloride USP, which is equivalent to 30mg of duloxetine. The body color is opaque white with imprint '747", while the cap color is opaque green with imprint 'B'. The medication guide should be dispensed separately to each patient. The product should be stored at 25°C (77°F) and kept out of the reach of children. The medication is manufactured by Laboratorios Dr. Esteve, S.A. in Barcelona, Spain, and packaged by Proficient Rx LP in Thousand Oaks, CA. The lot number is #00000 and the expiration date is 00/00/00. The product ID is PD070230 and the NDC number is 63187-702-30. The GTIN is oassa 187702304.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.